Sarcopenia is a risk factor for elevated aminotransferase in men independently of body mass index, dietary habits, and physical activity

Digestive and Liver Disease

Volumn 47, Issue 4, 2015, Pages 303-308

  Yoo, Ki Deok ^a   Jun, Dae Won ^a   Lee, Kang Nyeong ^a   Lee, Hang Lak ^a   Lee, Oh Young ^a   Yoon, Byung Chul ^a   Choi, Ho Soon ^a  

^a Hanyang University   (South Korea)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Muscle mass; Sarcopenia; Skeletal muscle index

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; AMINOTRANSFERASE;

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE MASS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; SARCOPENIA; SEX DIFFERENCE; SKELETAL MUSCLE; BLOOD; CLINICAL TRIAL; COMPLICATION; ENZYMOLOGY; INCIDENCE; LIVER DISEASES; METABOLISM; MOTOR ACTIVITY; MULTICENTER STUDY; NUTRITION; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; RADIOGRAPHY; SOUTH KOREA; YOUNG ADULT;

ABSORPTIOMETRY, PHOTON; ADULT; BODY MASS INDEX; FEMALE; FOOD HABITS; HUMANS; INCIDENCE; LIVER DISEASES; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCLE, SKELETAL; NUTRITION SURVEYS; REPUBLIC OF KOREA; RISK FACTORS; SARCOPENIA; TRANSAMINASES; YOUNG ADULT;

EID: 84925299132     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.12.014     Document Type: Article

References (22)

1. Liu C.J. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. Journal of Gastroenterology and Hepatology 2012, 27:1555-1560.
2. Yamakawa-Kobayashi K., Natsume M., Aoki S., et al. The combined effect of the T2DM susceptibility genes is an important risk factor for T2DM in non-obese Japanese: a population based case-control study. BMC Medical Genetics 2012, 13:11.
3. Aung K., Lorenzo C., Hinojosa M.A., et al. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. Journal of Clinical Endocrinology and Metabolism 2014, 99:462-468.
4. Dressler H., Smith C. Environmental, personal, and behavioral factors are related to body mass index in a group of multi-ethnic, low-income women. Journal of the Academy of Nutrition and Dietetics 2013, 113:1662-1668.
5. Lin Y.C., Chang P.F., Chang M.H., et al. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals. American Journal of Clinical Nutrition 2014, 99:869-874.
6. Levine M.E., Crimmins E.M. The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning. Obesity (Silver Spring) 2012, 20:2101-2106.
7. Esposito K., Chiodini P., Capuano A., et al. Fracture risk and bone mineral density in metabolic syndrome: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 2013, 98:3306-3314.
8. Lim K.I., Yang S.J., Kim T.N., et al. The association between the ratio of visceral fat to thigh muscle area and metabolic syndrome: the Korean Sarcopenic Obesity Study (KSOS). Clinical Endocrinology 2010, 73:588-594.
9. Lim S., Kim J.H., Yoon J.W., et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010, 33:1652-1654.
10. Cruz-Jentoft A.J., Baeyens J.P., Bauer J.M., et al. Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age and Ageing 2010, 39:412-423.
11. Guillet C., Boirie Y. Insulin resistance: a contributing factor to age-related muscle mass loss?. Diabetes and Metabolism 2005, 31. 5S20-26.
12. Kim Y.S., Lee Y., Chung Y.S., et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2012, 67:1107-1113.
13. Hong H.C., Hwang S.Y., Choi H.Y., et al. The relationship between sarcopenia and non-alcoholic fatty liver disease: the Korean sarcopenic obesity study. Hepatology 2014, 59:1772-1778.
14. Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Annals of Internal Medicine 2002, 137:1-10.
15. Kim T.N., Park M.S., Lim K.I., et al. Skeletal muscle mass to visceral fat area ratio is associated with metabolic syndrome and arterial stiffness: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Research and Clinical Practice 2011, 93:285-291.
16. Moon J.S., Yoon J.S., Won K.C., et al. The role of skeletal muscle in development of nonalcoholic fatty liver disease. Diabetes and Metabolism Journal 2013, 37:278-285.
17. Janssen I., Heymsfield S.B., Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. Journal of the American Geriatrics Society 2002, 50:889-896.
18. Kenny A.M., Dawson L., Kleppinger A., et al. Prevalence of sarcopenia and predictors of skeletal muscle mass in nonobese women who are long-term users of estrogen-replacement therapy. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2003, 58:M436-M440.
19. Newman A.B., Kupelian V., Visser M., et al. Sarcopenia: alternative definitions and associations with lower extremity function. Journal of the American Geriatrics Society 2003, 51:1602-1609.
20. Baumgartner R.N., Koehler K.M., Gallagher D., et al. Epidemiology of sarcopenia among the elderly in New Mexico. American Journal of Epidemiology 1998, 147:755-763.
21. Poynard T., Lebray P., Ingiliz P., et al. Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest). BMC Gastroenterology 2010, 10:10-40.
22. Fleming K.M., Aithal G.P., Solaymani-Dodaran M., et al. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. Journal of Hepatology 2008, 49:732-738.